Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
Eric L. Logigian(University of Rochester Medical Center), Christine Annis(MACOM (United States)), Alexander T. Pearson(University of Chicago), Charles A. Thornton(University of Rochester Medical Center), Cheryl A. Barbieri(MACOM (United States)), Michael McDermott(Unknown), William B. Martens(MACOM (United States)), Richard T. Moxley(Unknown), Nuran Dilek(MACOM (United States)), A. W. Wiegner(Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde)
Cited by 198
Related Papers
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra
|Arthritis & Rheumatism|2004|743
Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
|New England Journal of Medicine|2003|655
Comparing scientific abstracts generated by ChatGPT to real abstracts with detectors and blinded human reviewers
|npj Digital Medicine|2023|651